DOCSLIB.ORG

Encouraging Results in the Treatment of Haemorrhagic Cystitis with Estrogen – Report of 10 Cases and Review of the Literature

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Encouraging Results in the Treatment of Haemorrhagic Cystitis with Estrogen – Report of 10 Cases and Review of the Literature Bone Marrow Transplantation (2000) 25, 981–985 2000 Macmillan Publishers Ltd All rights reserved 0268–3369/00 $15.00 www.nature.com/bmt Encouraging results in the treatment of haemorrhagic cystitis with estrogen – report of 10 cases and review of the literature R Ordemann, R Naumann, G Geissler, M Bornhauser, U Schuler and G Ehninger Department of Medicine I, Technical University of Dresden, University Hospital ‘Carl Gustav Carus’, Dresden, Germany Summary: been published.14–16 Few have shown an encouraging effect with acceptable side-effects. Case reports about oral estro- Haemorrhagic cystitis (HC) after allogeneic haematopo- gen as an effective treatment of HC have prompted us to ietic stem cell transplantation (HSCT) or high-dose try this modality in affected patients.17–19 cyclophosphamide (CP) chemotherapy is a severe side- effect and can cause significant morbidity and mortality. In this report, we describe the clinical courses of 10 Patients and methods patients with HC and review the literature. The patients were treated with oral conjugated estrogen in an Ten consecutive cases of haemorrhagic cystitis after high- attempt to improve severe haemorrhagic cystitis. In dose chemotherapy and CP mobilisation were observed in seven patients positive effects were seen, haematuria the University Hospital of Dresden between 1 January 1997 resolved in all, but residual symptoms of dysuria and 31 December 1998. All patients treated with cyclophos- remained for longer periods. In one patient application phamide received mesna prophylaxis at a dose identical to of estrogen was interrupted because of hepatotoxicity. the CP dose for 24 h with an additional bolus of 40% before Two patients failed all treatment modalities including the start of CP infusion. Patients were required to have a oral estrogen because of terminal illness. We conclude normal serum bilirubin at the time of administration of oral that in the management of HC the administration of estrogen. Other causes of haematuria at this time were not oral conjugated estrogen should be considered. Bone seen. The clinical characteristics of the patients described Marrow Transplantation (2000) 25, 981–985. in this report are listed in Table 1. The severity of HC is Keywords: haemorrhagic cystitis; haematopoietic stem graded according to the scale published by Bearman and cell transplantation; cyclophosphamide; estrogen colleagues.13 Case 1 Haemorrhagic cystitis (HC) remains a well known compli- cation after high-dose cyclophosphamide (CP) or ifosfam- A 27-year-old man with paroxysmal nocturnal haemoglobi- ide, but other causes such as busulfan, etoposide, nuria (PNH) complained of haematuria, dysuria and polyu- irradiation, acute GVHD, viruses such as adenovirus, poly- ria 21 days after unrelated HLA-matched peripheral blood oma BK virus, cytomegalovirus and age in the allogeneic stem cell transplantation. The conditioning regime included population have also been implicated.1–9 The reported fre- busulfan (16 mg/kg), CP (200 mg/kg) and ATG quency ranges from 5 to 40% despite various attempts to (10 mg/kg). At the beginning, the HC was treated with prevent this complication.10 It is known that metabolites of hydration and analgesics (metamizole, buprenorphine). the oxazaphophorines alkylating agents, CP and ifosfamide Because of persistent symptoms, oral estrogen therapy was can induce urothelial toxicity and microvascular damage begun at 6 mg daily and increased to 12 mg (4 mg three and leads to HC.11,12 The clinical course of this compli- times a day). Bleeding resolved after 2 weeks and no cation is heterogeneous. The manifestations vary from further transfusion was needed. A cystoscopic washout was asymptomatic and transient microhaematuria to repeated not required. After 4 weeks the dose could be reduced to episodes of macrohaematuria with blood clots and bladder 2 mg daily. No residual symptoms of dysuria remained. pain and spasms. Some patients develop bladder tamponade The patient is alive with persistent complete remission of with urinary tract obstruction.13 Often there is no corre- the PNH. lation between the extent of therapy and development of severe haematuria. No definitive and effective therapy for the severe form of HC has been established. Many different Case 2 conservative and aggressive treatment regimes for HC have A 39-year-old woman with multiple myeloma (MM) developed haematuria and irritative voiding symptoms 7 days after high dose CP (4 g/m2) for peripheral stem cell Correspondence: Dr G Ehninger, Department of Medicine I, Technical University of Dresden, University Hospital ‘Carl Gustav Carus’, Fetscher- mobilisation. After application of 2 mg estrogen three times stra␤e 74, 01307 Dresden, Germany daily haematuria and dysuria greatly improved. Afterwards Received 22 September 1999; accepted 1 February 2000 the patient received a conditioning regimen with high-dose Treatment of haemorrhagic cystitis with estrogen R Ordemann et al 982 Table 1 Clinical characteristics of the patients No. Patient Age/Sex Diagnosis Therapy HC Responder Virus study 1 27/M PNH Unrelated PBSCT Mild Yes Negative 2 39/F MM High dose CP Mild Yes Negative 3 52/F MM Related PBSCT Severe Yes Negative 4 40/F CML Unrelated BMT Mild No Negative 5 31/M CML Related PBSCT (2 AG mismatch) Severe No Negative 6 28/M ALL Related PBSCT Severe Yes BK virus positive 7 38/M AML Unrelated BMT Severe Yes Negative 8 38/M AML Unrelated BMT Severe Yes Negative 9 24/F CML Unrelated PBSCT Moderate Yes BK virus positive 10 40/M CML Unrelated BMT Mild No BK virus positive melphalan (200 mg/m2) followed by an autologous PBSCT did not disappear in the next 2 weeks until death from without any complications. recurrent leukaemia. Case 3 Case 6 A 52-year-old woman developed gross haematuria with A 28-year-old man received total body irradiation (12 Gy), polyuria, dysuria and clots 30 days after receiving CP CP (120 mg/kg) and etoposide (45 mg/kg) as conditioning (120 mg/kg) and busulfan (16 mg/kg) before allogeneic regime for allogeneic related peripheral blood stem trans- related peripheral blood stem cell transplantation for mul- plantation for refractory relapse of ALL. Already during tiple myeloma. Cystoscopy was required because of a tran- the high-dose chemotherapy the patient developed haemor- sient postrenal kidney failure. During the next 8 weeks the rhagic cystitis with blood clots and urinary retention. Urine patient was treated with 4 mg estrogen three times daily. PCR testing showed polyoma BK virus to be present. Mul- The bleeding resolved and no further transfusion was tiple cystoscopic washouts and blood transfusion were needed. However, residual symptoms of dysuria remained required. 6 mg estrogen daily was started on day 7 after for a longer period. During the next 2 months complaints transplantation. The patient showed initial improvement have not recurred on a maintainance dose of 1 mg daily. and the estrogen dose was decreased. A relapse of HC Until now the patient lives in a stable remission of the occurred 24 days later. The estrogen dose was increased to multiple myeloma. 4 mg three times daily and the patient responded again until he died from recurrent leukaemia on day 81 post transplant. Case 4 Case 7 A 40-year-old woman with CML received high dose CP (200 mg/kg), busulfan (16 mg/kg) and ATG (10 mg/kg). A 38-year-old man had a severe macrohaematuria with Thirty days after matched unrelated bone marrow transplan- repeated bladder tamponade. The haemorrhagic cystitis tation the patient complained of haematuria, polyuria and began at day 5 after CP (120 mg/kg), busulfan (10 mg/kg) dysuria. After application of 4 mg estrogen three times and thiotepa (750 mg/m2) and allogeneic unrelated bone daily for 5 days the administration was interrupted because marrow transplantation for AML. Bleeding responded tran- of histological proven drug induced hepatosis. The macro- siently to continuous bladder irrigation and multiple cysto- haematuria continued for about 4 weeks. Residual symp- scopic washouts, diathermies and laser coagulations. Mul- toms of dysuria lasted for another month and then discon- tiple units of transfused packed red blood cells were tinued. The patient died from chronic GVHD on day 360 required. The clinical course was complicated by a post transplant. Coombs-positive autoimmune haemolytic anaemia and postrenal kidney failure which required transient haemo- Case 5 dialysis. Altogether the patient received 112 units of trans- fused packed red blood cells and more than 150 platelet A 31-year-old man with CML in blast crisis had severe HC transfusions. At day 70 post transplant estrogen therapy was 20 days after related two antigen mismatched peripheral started with 6 mg and increased to 12 mg daily (4 mg three blood stem cell transplantation for which he had received times daily). Haematuria improved slowly 11 days later and high-dose chemotherapy with CP (120 mg/kg), busulfan no further transfusion and cystoscopy were needed. (12.4 mg/kg) and ATG (10 mg/kg). Various therapies, including continuous bladder irrigation, repeated cysto- Case 8 scopic bladder washouts and platelet transfusions failed to control the haemorrhage, which required between 2 and 4 A 38-year-old man presented with gross haematuria and units of transfused packed red blood cells daily. The patient irritative voiding at day 4 after high-dose chemotherapy received 4 mg estrogen three times daily, but haematuria with CP (200 mg/kg), busulfan (16 mg/kg) and ATG Bone Marrow Transplantation Treatment of haemorrhagic cystitis with estrogen R Ordemann et al 983 (10 mg/kg) and allogeneic unrelated bone marrow trans- causing urinary tract obstruction (severe) occurred. plantation for AML in second remission. Cystoscopic Polyoma BK virus was implicated in three cases. washout was required because of bladder tamponade on day We started with 6 mg estrogen daily in three divided 19 post transplant. Continuous bladder irrigation could not doses and escalated until improvement of symptoms control the haematuria.
Load more

Recommended publications
  • Guidelines for Management of Acute Renal Failure (Acute Kidney Injury)
    Guidelines for management of Acute Renal Failure (Acute Kidney Injury) Children’s Kidney Centre University Hospital of Wales Cardiff CF14 4XW DISCLAIMER: These guidelines were produced in good faith by the author(s) reviewing available evidence/opinion. They were designed for use by paediatric nephrologists at the University Hospital of Wales, Cardiff for children under their care. They are neither policies nor protocols but are intended to serve only as guidelines. They are not intended to replace clinical judgment or dictate care of individual patients. Responsibility and decision-making (including checking drug doses) for a specific patient lie with the physician and staff caring for that particular patient. Version 1, S. Hegde/Feb 2009 Guidelines on management of Acute Renal Failure (Acute Kidney Injury) Definition of ARF (now referred to as AKI) • Acute renal failure is a sudden decline in glomerular filtration rate (usually marked by rise in serum creatinine & urea) which is potentially reversible with or without oliguria. • Oliguria defined as urine output <300ml/m²/day or < 0.5 ml/kg/h (<1 ml/kg/h in neonates). • Acute on chronic renal failure suggested by poor growth, history of polyuria and polydipsia, and evidence of renal osteodystrophy However, immediately after a kidney injury, serum creatinine & urea levels may be normal, and the only sign of a kidney injury may be decreased urine production. A rise in the creatinine level can result from medications (e.g., cimetidine, trimethoprim) that inhibit the kidney’s tubular secretion. A rise in the serum urea level can occur without renal injury, such as in GI or mucosal bleeding, steroid use, or protein loading.
    [Show full text]
  • Increase Thirst and Urination (Polydyspsia and Polyuria)
    Increase Thirst and Urination (Polydyspsia and Polyuria) 803-808-7387 www.gracepets.com What are the causes of increased thirst and urination? These clinical signs are non-specific and can be caused by many different diseases or conditions. Usually it is the production of excess, dilute urine that results in a compensatory increase in water consumption, but occasionally the condition is one of increased water intake resulting in the production of large volumes of dilute urine. The following is not a complete listing of the diseases that may result in increased thirst and urination. However it outlines the most common causes: Conditions related to the urinary and reproductive systems including kidney failure, infections of the kidneys or bladder, and infections of the uterus. Endocrine or hormone related conditions including hyperadrenocorticism and hypoadrenocorticism, hyperthyroidism, diabetes mellitus and diabetes insipidus. Liver disease, certain drugs, fever, pain and certain electrolyte imbalances may also result in increased thirst and urination. Rarely, a behavioral problem is at the root of increased drinking behavior. This list is huge! How can we possibly determine what the cause is in my pet? Certain diseases are more common in certain species (dogs versus cats) so this may narrow down the range of possibilities. In addition, the specific history of the pet, including a list of all medications and supplements that your pet has recently received, is helpful. This information, along with a physical examination, will often narrow the list further. A panel of screening tests will also exclude a large number of these conditions and may even provide a definitive diagnosis.
    [Show full text]
  • History & Physical Format
    History & Physical Format SUBJECTIVE (History) Identification name, address, tel.#, DOB, informant, referring provider CC (chief complaint) list of symptoms & duration. reason for seeking care HPI (history of present illness) - PQRST Provocative/palliative - precipitating/relieving Quality/quantity - character Region - location/radiation Severity - constant/intermittent Timing - onset/frequency/duration PMH (past medical /surgical history) general health, weight loss, hepatitis, rheumatic fever, mono, flu, arthritis, Ca, gout, asthma/COPD, pneumonia, thyroid dx, blood dyscrasias, ASCVD, HTN, UTIs, DM, seizures, operations, injuries, PUD/GERD, hospitalizations, psych hx Allergies Meds (Rx & OTC) SH (social history) birthplace, residence, education, occupation, marital status, ETOH, smoking, drugs, etc., sexual activity - MEN, WOMEN or BOTH CAGE Review Ever Feel Need to CUT DOWN Ever Felt ANNOYED by criticism of drinking Ever Had GUILTY Feelings Ever Taken Morning EYE OPENER FH (family history) age & cause of death of relatives' family diseases (CAD, CA, DM, psych) SUBJECTIVE (Review of Systems) skin, hair, nails - lesions, rashes, pruritis, changes in moles; change in distribution; lymph nodes - enlargement, pain bones , joints muscles - fractures, pain, stiffness, weakness, atrophy blood - anemia, bruising head - H/A, trauma, vertigo, syncope, seizures, memory eyes- visual loss, diplopia, trauma, inflammation glasses ears - deafness, tinnitis, discharge, pain nose - discharge, obstruction, epistaxis mouth - sores, gingival bleeding, teeth,
    [Show full text]
  • Nocturia: the Complex Role of the Heart, Kidneys, and Bladder
    EUF-773; No. of Pages 3 E U R O P E A N U R O L O G Y F O C U S X X X ( 2 0 1 9 ) X X X – X X X ava ilable at www.sciencedirect.com journa l homepage: www.europeanurology.com/eufocus Mini Review – Voiding Dysfunction Nocturia: The Complex Role of the Heart, Kidneys, and Bladder a,* a b Riccardo Lombardo , Andrea Tubaro , Fiona Burkhard a b Ospedale Sant’ Andrea, Sapienza University of Rome, Rome, Italy; Department of Urology, Inselspital University Hospital Bern, Bern, Switzerland Article info Abstract Article history: We review the role of the heart, kidneys, and bladder in the pathophysiology of nocturia Accepted July 25, 2019 and nocturnal polyuria. Lower urinary tract symptoms such as nocturia have often been associated with lower urinary tract dysfunction. It is known that the bladder contributes Associate Editor: to nocturia in the case of low functional capacity, urgency, and detrusor overactivity. Heart diseases, especially arterial hypertension and congestive heart failure, are closely Malte Rieken related to nocturnal polyuria. The main mechanisms include renal hyperfiltration and elevated atrial natriuretic peptide. A number of drugs frequently used in cardiovascular Keywords: disorders are implicated in nocturia; diuretics, calcium channel blockers, and b-blockers Nocturia induce nocturnal polyuria and thus nocturia, whereas alpha-blockers improve nocturia. Among the different forms of hypertension, nondipping arterial hypertension has been Nocturnal polyuria associated with a higher risk of nocturnal polyuria. Besides the role of the kidneys in Physiopathology nocturia linked to arterial hypertension, chronic kidney disease is an independent predictor of nocturia through an osmotic diuresis mechanism.
    [Show full text]
  • Obstruction of the Urinary Tract 2567
    Chapter 540 ◆ Obstruction of the Urinary Tract 2567 Table 540-1 Types and Causes of Urinary Tract Obstruction LOCATION CAUSE Infundibula Congenital Calculi Inflammatory (tuberculosis) Traumatic Postsurgical Neoplastic Renal pelvis Congenital (infundibulopelvic stenosis) Inflammatory (tuberculosis) Calculi Neoplasia (Wilms tumor, neuroblastoma) Ureteropelvic junction Congenital stenosis Chapter 540 Calculi Neoplasia Inflammatory Obstruction of the Postsurgical Traumatic Ureter Congenital obstructive megaureter Urinary Tract Midureteral structure Jack S. Elder Ureteral ectopia Ureterocele Retrocaval ureter Ureteral fibroepithelial polyps Most childhood obstructive lesions are congenital, although urinary Ureteral valves tract obstruction can be caused by trauma, neoplasia, calculi, inflam- Calculi matory processes, or surgical procedures. Obstructive lesions occur at Postsurgical any level from the urethral meatus to the calyceal infundibula (Table Extrinsic compression 540-1). The pathophysiologic effects of obstruction depend on its level, Neoplasia (neuroblastoma, lymphoma, and other retroperitoneal or pelvic the extent of involvement, the child’s age at onset, and whether it is tumors) acute or chronic. Inflammatory (Crohn disease, chronic granulomatous disease) ETIOLOGY Hematoma, urinoma Ureteral obstruction occurring early in fetal life results in renal dys- Lymphocele plasia, ranging from multicystic kidney, which is associated with ure- Retroperitoneal fibrosis teral or pelvic atresia (see Fig. 537-2 in Chapter 537), to various
    [Show full text]
  • Nocturia and Night-Time Incontinence
    cmE caSE PrESENTaTION Nocturia and Night-Time Incontinence David r. staskin, MD LEarNINg ObjEcTIvES: Associate Professor of Urology 1. Discuss the definitions of Nocturia and Director, Female Urology and Male Voiding Dysfunction st. Elizabeth’s Medical center Night-Time Incontinence (N & NTI); tufts University school of Medicine, Boston, MA 2. Identify the etiology and pathophysiology of N and NTI; Disclosure record for David R. Staskin, M.D. 3. Evaluate the symptoms of N and NTI Last reviewed/edited this information on January 10, 2011. Uroplasty: Consultant or Advisor; American Medical Systems: and the differential diagnosis for these Consultant or Advisor; Astellas: Consultant or Advisor; symptoms; and Pfizer: Consultant or Advisor; Glaxo: Consultant or Advisor; Allergan: Consultant or Advisor 4. Describe appropriate treatment strategies for N and NTI into daily practice. PhysicIaN accreditation STatement PhysicIaN credit STatement The University of North Texas Health Science Center at Fort Worth Office of Professional The University of North Texas Health Science Center has requested that the AOA and Continuing Education is accredited by the American Osteopathic Association to Council on Continuing Medical Education approve this program for 1 hour of AOA award continuing medical education to physicians. Category 2B CME credits. Approval is currently pending. The University of North Texas Health Science Center at Fort Worth Office of The University of North Texas Health Science Center at Fort Worth designates this Professional and Continuing Education is accredited by the American Council for enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Continuing Medical Education (ACCME) to provide continuing medical education Physicians should claim only the credit commensurate with the extent of their for physicians.
    [Show full text]
  • Chapter 19: Nocturia in Elderly Persons and Nocturnal Polyuria
    Chapter 19: Nocturia in Elderly Persons and Nocturnal Polyuria Dean A. Kujubu Department of Medicine, UCLA School of Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California Nocturia is defined by the International Conti- Conditions such as congestive heart failure, ne- nence Society as the interruption of sleep one or phrotic syndrome, autonomic neuropathy, and ve- more times at night to void.1 Although nocturia is nous insufficiency lead to interstitial edema forma- relatively uncommon among younger adults, by 80 tion during the day. Mobilization of the yr of age, the prevalence rises to 80 to 90% in both accumulated interstitial fluid while recumbent re- men and women.2 The presence of nocturia dis- sults in nocturia. Obstructive sleep apnea is associ- rupts sleep, leading to daytime somnolence, depres- ated with excessive atrial natriuretic peptide pro- sive symptoms, cognitive dysfunction, and a re- duction. Neurologic dieases, such as Alzheimer’s duced sense of well being and quality of life.3 disease and Parkinson’s disease, are associated with Moreover, nocturia is associated with an increased alterations in the diurnal secretory pattern of neu- risk morbidity and even mortality.4,5 rohormones, such as natriuretic peptides and anti- diuretic hormone. Patients with chronic kidney dis- ease are unable to maximally concentrate their PATHYPHYSIOLOGY urine and often must void at night. In many cases, the cause of nocturnal polyuria is Although it is commonly assumed that nocturia in undefined. In idiopathic nocturnal polyuria, As- the elderly is primarily a urologic problem, such plund and Aberg8 suggested that anti-diuretic hor- thinking is inaccurate.
    [Show full text]
  • Overactive Bladder Syndrome Management and Treatment Options Janine Arnold Nicholas Mcleod Ruban Thani-Gasalam Prem Rashid
    CLINICAL Overactive bladder syndrome Management and treatment options Janine Arnold Nicholas McLeod Ruban Thani-Gasalam Prem Rashid When compared with demographically matched Background controls, patients with OBS have:10,11 Overactive bladder syndrome is a symptom-based clinical diagnosis. It is • significantly less work productivity characterised by urinary urgency, frequency and nocturia, with or without urge • less sexual satisfaction and more erectile urinary incontinence. These symptoms can often be managed in the primary care dysfunction setting. • higher rates of depressive symptoms Objective • significantly poorer mental health This article provides a review on overactive bladder syndrome and provides advice • poorer quality of sleep. on management for the general practitioner. Postmenopausal women with urge incontinence Discussion have a significantly higher risk of falling and Overactive bladder syndrome can have a significant effect on quality of life, and sustaining a fracture than women without urge affects 12–17% of the population. Prevalence increases with age. The management incontinence.4 of overactive bladder syndrome involves exclusion of underlying pathology. First line treatment includes lifestyle interventions, pelvic floor exercises, bladder Causes training and antimuscarinic agents. Failure of conservative management The symptoms of OBS have many potential causes necessitates urology referral. Second line therapies are more invasive, and include and contributing factors. Normal storage of urine botulinum toxin, neuromodulation or surgical interventions such as augmentation is dependent on spinal reflex mechanisms that cystoplasty or urinary diversion. activate sympathetic and somatic pathways to the Keywords urethral outlet and tonic inhibitory systems in the overactive urinary bladder; urological diseases; urinary incontinence brain that suppress the parasympathetic excitatory outflow to the urinary bladder.4 The normal bladder fills like a compliant balloon, with pressure lower than urethral resistance.
    [Show full text]
  • Georgia Urology, Pa Review of Systems Name___Date of Birth
    GEORGIA UROLOGY, P.A. REVIEW OF SYSTEMS NAME_____________________________________________ DATE OF BIRTH______________________ DATE ___________________ PLEASE CHECK ALL THAT APPLY TODAY 1NONE CONSTITUTIONAL GASTROINTESTINAL METABOLIC/ENDOCRINE □ Activity change □ Abdominal pain □ Cold/heat intolerance □ Decreased appetite □ Change in bowel habits □ Excessive perspiration □ Fatigue □ Blood in stool □ Goiter □ Fever □ Indigestion/Heartburn □ Infertility □ Insomnia □ Jaundice □ Low blood sugar (hypoglycemia) □ Irritability □ Nausea □ Excessive thirst (polydipsia) □ Malaise □ Reflux □ Excessive hunger (polyphagia) □ Night sweats □ Excessive urination (polyuria) □ Recent weight gain URINARY (GENITOURINARY) □ Recent weight loss □ Back pain NEUROLOGIC/PSYCHIATRIC □ Change in urine color □ Altered ability to speak (aphasia) HEENT □ Cloudy urine □ Focal weakness □ Headaches □ Decreased stream □ Gait disturbance □ Vision loss □ Painful urination (dysuria) □ Loss of coordination □ Hearing loss □ Flank pain □ Light-headed/dizziness □ Tinnitus □ Frequency □ Loss of consciousness/fainting □ Ear infections □ Groin mass □ Memory loss □ Vertigo □ Blood in urine (hematuria) □ Numbness/tingling (paresthesias) □ Nosebleeds (epistaxis) □ Hesitancy □ Seizures □ Sinus infections □ Incontinence □ Tremors □ Difficulty swallowing □ Low urine output □ Emotional disturbance □ Sore throats □ Get up at night to urinate (nocturia) □ Passing stone(s) SKIN (DERMATOLOGIC) RESPIRATORY □ Excessive urination (polyuria) □ Contact allergies □ Pain during breathing □ Urgency
    [Show full text]
  • Nocturnal Enuresis in General Practice
    www.bpac.org.nz keyword: enuresis The investigation and management of nocturnal enuresis in General Practice Expert Reviewer: Associate Professor David Reith, Department of Women’s and Children’s Health, Dunedin School of Medicine, University of Otago Key Concepts ■ Nocturnal enuresis is common and children usually grow out of it Considerations: ■ Simple advice regarding fluids and use of rewards may be appropriate in the first ▪ At what age is bedwetting abnormal? instance ▪ What is it normally due to? ■ If the child and their family are motivated to ▪ Are any investigations needed? try treatment, then the use of bed alarms with ▪ What advice can I give to parents? support offer the best chance of long-term success ▪ When should I refer? ■ Desmopressin can be prescribed with caution ▪ What non-drug treatments are recommended? for occasional short term use ▪ What medications are recommended? 14 | BPJ | Issue 14 Defining bedwetting Primary nocturnal enuresis is bedwetting in a child who A recent study found that children with the most frequent has never been consistently dry at nights for a period of bedwetting were more likely to persist with the problem.3 six months. It is thought that fewer than half of parents with a child Secondary nocturnal enuresis is bedwetting in a child with nocturnal enuresis, consult their doctor about the who has previously had a period of at least six months problem.4 of dryness. Bedwetting can place considerable stress on the individuals Causes of bedwetting affected and their families. Although this article is aimed The exact cause of nocturnal enuresis is unknown.
    [Show full text]
  • The Classification of Enuresis by E
    Arch Dis Child: first published as 10.1136/adc.28.141.392 on 1 October 1953. Downloaded from THE CLASSIFICATION OF ENURESIS BY E. M. POULTON and E. HINDEN From Whipps Cross Hospital, London (RECEIVED FOR PUBLICATION MAY 15, 1953) During the past three years at Whipps Cross The mean 24-hour excretion is the sum of the Hospital we have investigated 200 children suffering mean diurnal and nocturnal excretions. from enuresis. We define this condition as the The day-to-night ratio (D/N) is the ratio between involuntary voiding of urine by distinct acts of the mean diurnal and the mean nocturnal excretions. micturition. There are two elements here. The first, The maximum functional bladder capacity is the that the act is involuntary, may well be governed by greatest volume of urine passed in one act during psychological factors. But before a bladder will the period of observation. empty it must be filled, so it seemed important to The mean functional bladder capacity is the mean disentangle the mechanical factors which are respon- of all the volumes passed in separate acts during the sible for filling the bladder. In a previous paper day period, i.e. at times chosen by the patient. (Poulton, 1952) it was shown that children will not The N/B ratio is the ratio between the mean invariably wake in order to empty the bladder should nocturnal excretion and the mean functional bladder Protected by copyright. it fill during sleep: they are just as likely to wet the capacity. This ratio indicates the number of times the bed.
    [Show full text]
  • Voidingdysfunction Inside Pages
    Getting Ready For Certification: Voiding Dysfunction Jeffrey Guse 1. The definition of dysuria is: Dorland’s, 2007). Anuria, also called anuresis, is a. a lack of the ability to urinate. defined as the lack of urination or urine produc- b. failure of urinary excretion. tion of less than 100 ml per day (Dorland’s, 2007). c. accumulation of urine within the bladder. 2. C – Anuria, also called anuresis, is defined as the d. painful urination. lack of urination or urine production of less than 100 ml per day secondary to pre-renal, renal or 2. All of the following are true of anuria except: post-renal causes (Dorland’s, 2007; Tanagho & a. is often caused by renal failure. McAninch, 2008; Van Arsdalen, 2007, p. 41). b. may occur due to severe obstruction. Oliguria, a less extreme reduction in urine pro- c. defined as urinary output of less than 500 mL duction defined as urinary output of less than per day. 500 mL per day (Mosby's, 2009). d. may occur with end stage renal disease. 3. B – Polyuria is defined as an excessive produc- tion of urine or the excretion of an abnormally 3. All of the following are true of polyuria except: large quantity of urine on a daily basis (Mosby's, a. characterized by large volumes of urine. 2009; Van Arsdalen, 2007, p. 41). Polydipsia, b. always appears in conjunction with polydip- defined as excessive or abnormal thirst, can sia. appear in conjunction with polyuria, but not c. is physiologically normal in some circum- always. stances. 4. C – Inability to completely empty the bladder and d.
    [Show full text]